Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > Could Pharmala benefit from this partnership? ??

<< Previous

Bullboard Posts

Next >>

Comment by Firepokeron Mar 26, 2024 9:39pm

56 Views

Post# 35954452

RE:Could Pharmala benefit from this partnership? ??

Not to confuse...the partnership I wrote was not with us, but Emyria with another medical group to supply treatent for first responders.
But since we supplied Emyria in the past (Feb 2023) for clinical trials...maybe we will be approached again with another order...
Pharmala has made allies supplying clinical trials all over the world...links in a chain.

<< Previous

Bullboard Posts

Next >>

Looking at: Is Taylor Swift the key to solving traffic in Toronto?